4.7 Review

Advanced drug delivery 2020 and beyond: Perspectives on the future

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 158, 期 -, 页码 4-16

出版社

ELSEVIER
DOI: 10.1016/j.addr.2020.06.018

关键词

Drug delivery issues; Preclinical-clinical correlation; Nanomedicine; Drug prices; Optimal target diseases; Diverse technologies

资金

  1. National Institutes of Health [DK114015]
  2. Showalter Research Trust Fund

向作者/读者索取更多资源

Drug delivery systems are developed to maximize drug efficacy and minimize side effects. As drug delivery technologies improve, the drug becomes safer and more comfortable for patients to use. During the last seven decades, extraordinary progress has been made in drug delivery technologies, such as systems for long-term delivery for months and years, localized delivery, and targeted delivery. The advances, however, will face a next phase considering the future technologies we need to overcome many physicochemical barriers for new formulation development and biological unknowns for treating various diseases. For immediate and long-term progress into the future, the drug delivery field should use time and resources for more translatable research ideas. The drug delivery discipline has to continue working on basic, applied, translational, and clinical research in a concerted manner to produce drug delivery systems that work for patients. It is a time to focus our attention on things that matter. It is also a time to develop realistic research goals and outcomes, diversify drug delivery technologies, and take the collective responsibility for our actions. (C) 2020 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据